Despite years of steady growth, investors have abandoned the stock featured this month because they believe the business is fading – it is being viewed almost like an Old Economy company, even though it is actually a technological pioneer. This company is poised to flip the narrative, sending the stock higher as investors realize it is an AI winner.
Some rare companies are so dominant in the marketplace that their brands actually become the business. The company featured this month is so dominant in its field that it should have been included in the “Legal Monopolies” portfolio category, but that legality is being called into question by the U.S. federal government.
What you are looking for in smart, conservative investing is the very small number of businesses that will compound your wealth over a very long period of time, at market-beating rates. How many stocks can do this? Porter provides answers.
To maximize your future returns, it’s important that you buy great businesses when you can acquire them for substantially less than their intrinsic value. Here’s a real, current example of a great business trading at a truly attractive price.
Stocks in the S&P 500 are currently trading at sky-high valuations. With a weakening economy, it’s only a matter of time before share prices fall to levels at which valuation multiples decline to historical averages.
The top 10% of earners have been driving the economy. But now the data shows that even this segment of society is slowing their spending, causing key sectors of the economy to signal trouble ahead.
Porter outlines why this national homebuilder has become a superb business. He explains why it’s positioned to become a great, long-term compounder.
There has never been a more powerful consumer brand that is more beloved than Coke. And it’s been a great investment… $40 invested in 1919 would have turned into more than $600,000 by now. In today’s issue, Porter explains why…
To answer a reader’s question, Porter does some research on Philip Morris International and discovers that the nicotine maker produces a great return on its tangible assets – and manages to buy them with very cheap debt. His conclusion? That’s a great business.
Can a company that sells weight-loss drugs and a company that sells chocolate and candy both co-exist and both succeed? In this Daily Journal, we explore how Novo Nordisk and Hershey lose or win in the new world of fat shots.